Why the study?
Does the presence of concurrent chronic total occlusion impact 1-year mortality differently in men and women presenting with STEMI?
Population
2,020 patients referred with ST-elevation myocardial infarction between 2006 and 2011, 24% female. Women…
Comparison
Multivessel disease with 1 or >1 concurrent… vs Single vessel disease or multivessel disease…
Design
Cohort
Follow-up
1 year
Key result
Concurrent chronic total occlusion in STEMI patients independently predicted 1-year mortality in both women (HR 3.58; 95% CI 1.69-7.18) and men (HR 2.19; 95% CI 1.20-3.97).
Authors
Loading...
Concurrent CTO in STEMI was associated with higher 1-year mortality; leaves open gender-specific prognostic value and management implications.
Cohort (n=2,020)
Does the presence of concurrent chronic total occlusion impact 1-year mortality differently in men and women presenting with STEMI?
Hazard Ratio: 3.58 (95% CI 1.69–7.18)
p-value: p=<0.0001
Concurrent CTO in STEMI patients is equally prevalent in men and women and serves as a strong independent predictor of 1-year mortality in both sexes, though women experience significantly higher overall mortality.
Bataille et al. (2012) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=2,020). Concurrent chronic total occlusion (CTO) vs. No concurrent CTO (single vessel disease or multivessel disease without CTO) was evaluated on 1-year mortality (HR 3.58, 95% CI 1.69-7.18, p=<0.0001). Concurrent chronic total occlusion in STEMI patients independently predicted 1-year mortality in both women (HR 3.58; 95% CI 1.69-7.18) and men (HR 2.19; 95% CI 1.20-3.97).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: